PRESS-RELEASE ·Filed Aug 3, 2026
Press release · Earnings
Latest settled — T+20d
SPRY ▲ +9.89% at T+20d
NEUTRAL call +9.89% · α vs SPY +8.65% · entry $5.46 → $6.00
Latest observation: T+58 +50.51% FF3 residual α
T+1d
-2.56%
call -2.56% · α -4.37%
$5.32
settled 3mo ago
T+5d
+8.24%
call +8.24% · α +6.21%
$5.91
settled 3mo ago
T+20d
+9.89%
call +9.89% · α +8.65%
$6.00
settled 8w ago
T+60d
Pending
in 23h
Price Chart
Loading chart...
Executive Summary
ARS Pharmaceuticals, Inc. announced it will host a conference call on August 13 to discuss its Q2 2026 results.
Key Facts
- ARS Pharmaceuticals, Inc. announced it will host a conference call on August 13 to discuss its Q2 2026 results.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3337400 |
13 reports for SPRY
67% Hit rate @ T+1 Went positive at some point 3 of 3 best @ T+60▲ +32.03%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | 144 | $4.29 $4.18 | ▲ +2.56% | ▲ +3.09% | $4.03 (+6.06%) |
Sep 28, 2026 28d ago | Court Ruling | $4.40 $4.31 | ▼ −2.05% | ▼ −1.84% | $4.03 (−8.41%) |
Sep 16, 2026 5w ago | Court Ruling | $4.15 $4.11 | ▼ −0.96% | ▼ −0.84% | $4.03 (−2.89%) |
Aug 3, 2026 12w ago | Press Release | $5.46 $5.32 | ▼ −2.56% | ▼ −4.37% | $4.03 (−26.19%) |
Jul 17, 2026 14w ago | Court Ruling | $6.44 $6.36 | ▼ −1.24% | ▼ −2.08% | $4.03 (−37.42%) |
Jul 7, 2026 15w ago | 8-K | $8.10 $7.88 | ▼ −2.72% | ▼ −3.56% | $4.03 (−50.25%) |
Jun 12, 2026 19w ago | Insider Cluster | $9.81 $9.70 | ▼ −1.12% | ▼ −0.53% | $4.03 (−58.92%) |
May 15, 2026 23w ago | 8-K | $7.43 $7.30 | ▼ −1.68% | ▼ −1.62% | $4.03 (−45.72%) |
May 15, 2026 23w ago | Press Release | $7.43 $7.30 | ▲ +1.68% | ▲ +1.62% | $4.03 (+45.72%) |
May 13, 2026 23w ago | 8-K | $8.01 $7.94 | ▼ −0.87% | ▼ −1.65% | $4.03 (−49.69%) |
Showing 10 of 13
US Market Status
Market Closed — Opens in 23m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers